pentobarbital has been researched along with Fetal Resorption in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Fetal Resorption: The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes-Carneiro, MR | 1 |
| De-Oliveira, AC | 1 |
| De-Carvalho, RR | 1 |
| Araujo, IB | 1 |
| Souza, CA | 1 |
| Kuriyama, SN | 1 |
| Paumgartten, FJ | 1 |
1 other study available for pentobarbital and Fetal Resorption
| Article | Year |
|---|---|
Inhibition of cyclophosphamide-induced teratogenesis by beta-ionone.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Cyclophosphamide; Cytochrome P-450 CYP2B1; Drug I | 2003 |